26S-28810-63269
2 vaccinations
5 coded responses
22 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 606 / IL
- Registered
- 2022-06-29
- Relationship
- Child or adolescent in my care
- Guardian
- WNF-22834-62144
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Dose 1 — Moderna
-
2022-06-29
Registered in v-safe
- 2022-06-29
- 2022-06-30
- 2022-07-01
- 2022-07-02
- 2022-07-09
- 2022-07-16
- 2022-07-23
-
2022-07-30
Dose 2 — Moderna
- 2022-07-30
-
2022-07-31
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-08-01
- 2022-08-02
- 2022-08-03
- 2022-08-04
-
2022-08-05
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-08-06
-
2022-08-13
Survey response — day 14, dose 2, under 3MedDRA: Rash — Feeling: GoodFree text: Rash of unknown origin on faceMedDRA releases: 2024-11 · check-in free text available
- 2022-08-20
- 2022-08-27
-
2022-09-03
Survey response — day 35, dose 2, under 3MedDRA: Pyrexia — Feeling: Fair · Be unable to work or attend schoolFree text: FeverMedDRA releases: 2024-11 · check-in free text available
-
2022-09-10
Survey response — day 42, dose 2, under 3MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever for three daysMedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Survey response — 3 months, dose 2, under 3MedDRA: Ear infection, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Congestion, ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-01
-
2023-01-28
Survey response — 6 months, dose 2, under 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Moderna | No |
| 2 | 2022-07-30 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-29 | Unsuccessful |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Rash of unknown origin on face
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Fever
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Fever for three days
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Congestion, ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release